<?xml version="1.0" encoding="UTF-8"?>
<notes id="FPar1">
 <title>Ethics approval and consent to participate</title>
 <p id="Par44">The core protocol used by the GIHSN was approved by the Human Research Ethics Committee (Medical) of the University of the Witwatersrand, South Africa; the Ethical Committee of the Hospital Na Bulovce, Czech Republic; the Local Ethics Committee at the Federal State Budget Institution “Smorodintsev Research Institute of Influenza” of the Ministry of Health of the Russian Federation; CEIC Direccion General de Salud Publica/Centro Superior de Investigación en Salud Pública of FISABIO, Spain; KEMRI Scientific and Ethics Review Unit of the Kenya Medical Research Institute, Kenya; The local Ethic Committee of Hospital #1 for Infectious Diseases of Moscow Health Department of the Federal State Budgetary Healthcare Institution Hospital #1 for Infectious Diseases of the Moscow Health Department, Moscow, Russia; the Research Ethics Board of the Nova Scotia Health Authority, Canada; the Bioethics Committee of the National Institute for Infectious Diseases “Prof. Dr. Matei Bals”, Bucharest, Romania; the Ethical committee of the Institute of Public Health Vojvodina, Serbia; the Institute Ethics Committee of the Sher-i Kashmir Institute of Medical Sciences, Srinagar, India; Comité de Ética en Investigación and the Comité de Investigacion Institucional, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico; Comité de Protection des Personnes (CPP) Ile de France IV, Hôpital Saint-Louis, France; Comité de bioética del Hospital Dr. Alejandro Posadas, Argentina; and the Fudan University School of Public Health Institution Review Board, China.</p>
 <p id="Par45">All participants or their legal representatives provided written informed consent.</p>
 <p id="Par46">Administrative permissions were not required to access the raw data from GIHSN.</p>
</notes>
